The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

Clinical trial NCT02577926 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02577926
Sponsor: RWTH Aachen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Polycythemia Vera (PV)Essential Thrombocythemia (ET)

Start date: 2015-10-01
Primary completion: 2027-12-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.